India’s Biocon Biologics agrees to buy Viatris biosimilar assets for up to $3.35B
Maks_Lab/iStock by way of Getty Photographs India's Biocon Biologics agreed to amass Viatris Inc.'s biosimilar ...
Read moreMaks_Lab/iStock by way of Getty Photographs India's Biocon Biologics agreed to amass Viatris Inc.'s biosimilar ...
Read moreOn the BSE, the inventory opened at Rs 363.00, then jumped 2.61 per cent and ...
Read more Copyright © 2021 198 China News.
All Rights Reserved.
Copyright © 2021 198 China News.
All Rights Reserved.